Shekhat Denil Nanji 4
4 · MIRA PHARMACEUTICALS, INC. · Filed Oct 3, 2025
Insider Transaction Report
Form 4
Shekhat Denil Nanji
Director
Transactions
- Award
Common Stock
2025-10-01$1.35/sh+22,378$30,210→ 22,378 total
Footnotes (1)
- [F1]Represents 22,378 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc.